These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12481834)

  • 1. Clinical significance of the emergence of bacterial resistance in the hospital environment.
    Hosein IK; Hill DW; Jenkins LE; Magee JT
    Symp Ser Soc Appl Microbiol; 2002; (31):90S-97S. PubMed ID: 12481834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of the emergence of bacterial resistance in the hospital environment.
    Hosein IK; Hill DW; Jenkins LE; Magee JT
    J Appl Microbiol; 2002; 92 Suppl():90S-7S. PubMed ID: 12000618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlling antimicrobial resistance in the hospital.
    Anderson DJ; Kaye KS
    Infect Dis Clin North Am; 2009 Dec; 23(4):847-64, vii-viii. PubMed ID: 19909887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibiotic resistance--bacteria fight back].
    Tambić Andrasević A
    Acta Med Croatica; 2004; 58(4):245-50. PubMed ID: 15700679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Horizontal gene transfer-emerging multidrug resistance in hospital bacteria.
    Dzidic S; Bedeković V
    Acta Pharmacol Sin; 2003 Jun; 24(6):519-26. PubMed ID: 12791177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on antimicrobial chemotherapy: 2. The mechanisms of antibiotic resistance.
    Smith A; Bagg J
    Dent Update; 1998 Jun; 25(5):203-4, 206-8. PubMed ID: 18170955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance in the hospital setting: impact, trends, and infection control measures.
    Stein GE
    Pharmacotherapy; 2005 Oct; 25(10 Pt 2):44S-54S. PubMed ID: 16178675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic resistance and policy in Belgium.
    Goossens H
    Verh K Acad Geneeskd Belg; 2000; 62(5):439-69. PubMed ID: 11144690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost of Gram-negative resistance.
    Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
    Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal use of antibiotic resistance surveillance systems.
    Critchley IA; Karlowsky JA
    Clin Microbiol Infect; 2004 Jun; 10(6):502-11. PubMed ID: 15191377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New strategies to identify patients harbouring antibiotic-resistant bacteria at hospital admission.
    Tacconelli E
    Clin Microbiol Infect; 2006 Feb; 12(2):102-9. PubMed ID: 16441446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of hospital hygiene in the reduction of antibiotic resistance].
    Pittet D
    Bull Acad Natl Med; 2004; 188(8):1269-80; discussion 1280-1. PubMed ID: 15918657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic and biocide resistance in bacteria: introduction.
    Russell AD
    Symp Ser Soc Appl Microbiol; 2002; (31):1S-3S. PubMed ID: 12481823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing antimicrobial resistance through appropriate antibiotic usage in Singapore.
    Hsu LY; Kwa AL; Lye DC; Chlebicki MP; Tan TY; Ling ML; Wong SY; Goh LG
    Singapore Med J; 2008 Oct; 49(10):749-55. PubMed ID: 18946605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic-resistant organisms in the neonatal intensive care unit.
    Bizzarro MJ; Gallagher PG
    Semin Perinatol; 2007 Feb; 31(1):26-32. PubMed ID: 17317424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs.
    Geissler A; Gerbeaux P; Granier I; Blanc P; Facon K; Durand-Gasselin J
    Intensive Care Med; 2003 Jan; 29(1):49-54. PubMed ID: 12528022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Important aspects of nosocomial bacterial resistance and its management.
    Kandelaki G; Tsertsvadze T; Macharashvili N; Esugbaia M; Gogichaishvili Sh
    Georgian Med News; 2008 Dec; (165):49-54. PubMed ID: 19124917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance in gram-positive bacteria.
    Rice LB
    Am J Med; 2006 Jun; 119(6 Suppl 1):S11-9; discussion S62-70. PubMed ID: 16735146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of an intensive care unit rotating empiric antibiotic schedule on the development of hospital-acquired infections on the non-intensive care unit ward.
    Hughes MG; Evans HL; Chong TW; Smith RL; Raymond DP; Pelletier SJ; Pruett TL; Sawyer RG
    Crit Care Med; 2004 Jan; 32(1):53-60. PubMed ID: 14707559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.